Literature DB >> 33329355

Resting State Functional Connectivity Is Decreased Globally Across the C9orf72 Mutation Spectrum.

Rachel F Smallwood Shoukry1, Michael G Clark1, Mary Kay Floeter1.   

Abstract

A repeat expansion mutation in the C9orf72 gene causes amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), or symptoms of both, and has been associated with gray and white matter changes in brain MRI scans. We used graph theory to examine the network properties of brain function at rest in a population of mixed-phenotype C9orf72 mutation carriers (C9+). Twenty-five C9+ subjects (pre-symptomatic, or diagnosed with ALS, behavioral variant FTD (bvFTD), or both ALS and FTD) and twenty-six healthy controls underwent resting state fMRI. When comparing all C9+ subjects with healthy controls, both global and connection-specific decreases in resting state connectivity were observed, with no substantial reorganization of network hubs. However, when analyzing subgroups of the symptomatic C9+ patients, those with bvFTD (with and without comorbid ALS) show remarkable reorganization of hubs compared to patients with ALS alone (without bvFTD), indicating that subcortical regions become more connected in the network relative to other regions. Additionally, network connectivity measures of the right hippocampus and bilateral thalami increased with increasing scores on the Frontal Behavioral Inventory, indicative of worsening behavioral impairment. These results indicate that while C9orf72 mutation carriers across the ALS-FTD spectrum have global decreased resting state brain connectivity, phenotype-specific effects can also be observed at more local network levels.
Copyright © 2020 Smallwood Shoukry, Clark and Floeter.

Entities:  

Keywords:  C9orf72; amyotrophic lateral sclerosis; behavioral variant frontotemporal dementia; graph theory; pre-symptomatic; resting state fMRI

Year:  2020        PMID: 33329355      PMCID: PMC7710968          DOI: 10.3389/fneur.2020.598474

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


Introduction

A repeat expansion mutation in the C9orf72 gene is the most frequent cause of familial amyotrophic lateral sclerosis (ALS) and familial frontotemporal dementia (FTD) in populations of Northern European origin (1, 2) accounting for 5–10% of sporadic cases of these disorders (3). Carriers of the C9orf72 mutation (hereafter referred to as C9+) can present with clinical symptoms of ALS, FTD, or with combinations of motor, cognitive, and behavioral symptoms (4–7). Compared to patients with sporadic ALS or FTD, neuroimaging studies in C9+ ALS and FTD patients show more pronounced atrophy, particularly of subcortical structures and extramotor cortical regions (4, 8–15). Although subtle structural changes can be detected in groups of pre-symptomatic C9+ carriers (9, 16–18), most structural changes are found later in the disease course, when symptoms are manifest. In individual C9+ carriers, the structural changes may represent a hybrid pattern between those described for sporadic ALS and sporadic FTD, appearing to reflect the relative balance of motor and cognitive-behavioral dysfunction (10, 19–21). Functional connectivity changes also occur in patients with ALS and FTD. In sporadic and C9+ FTD, intrinsic functional connectivity is reduced in the salience networks, frontal and temporal regions, and thalamic networks (13, 22–24). Findings from resting state fMRI studies in sporadic ALS are less consistent. Most reports find increased connectivity, particularly in the sensorimotor network and default mode network (25–28). However, others report decreased connectivity (29–32), or mixtures of increased and decreased network connectivity (33–36). We hypothesized that functional imaging in C9+ carriers would show a hybrid pattern on a continuum of those seen in ALS and FTD reflecting the relative balance of motor and cognitive-behavioral dysfunction in each patient. To examine this hypothesis, we evaluated changes in network measures and their association with clinical measures of motor and cognitive-behavioral dysfunction using graph theory metrics. In this analysis, each brain region is represented as a node and the relationship between two brain regions is represented as an edge connecting the two nodes (37). Graph theory allows us to quantify whole-brain network properties, as well as how regions interact with each other as part of a larger network. We first compared differences in network measures of functional connectivity in a heterogeneous group of C9+ carriers to healthy controls to identify changes associated with the C9orf72 mutation itself. We then compared C9+ carriers with ALS alone (C9+ FTD-) to C9+ patients with behavioral variant FTD (bvFTD) or ALS-FTD within the cohort. We hypothesized that C9+ with bvFTD/ALS-FTD would exhibit changes in networks associated with cognitive-behavioral function whereas C9+ FTDALS patients would exhibit changes in motor networks, and that network measures would correlate with clinical measures of motor or cognitive-behavioral function.

Methods

Participants

Twenty-five carriers of the C9orf72 expansion mutation (Table 1) were recruited from across the United States though online advertising, organizational outreach, and physician referrals between 2013 and 2016. All subjects gave written informed consent in accordance with an IRB-approved protocol. Inclusion criteria required the C9+ subjects to have >30 repeats in the C9orf72 gene as established by repeat prime polymerase chain reaction in a CLIA certified lab. They were not excluded for having other comorbid conditions. All C9+ subjects were examined by an experienced neurologist and underwent electromyography and cognitive testing to determine their clinical diagnosis as previously reported (10). ALS was diagnosed using the 2015 revised El Escorial criteria (38). The International Consensus Criteria for behavioral variant FTD (39) were used for diagnosis of possible, probable, or definite bvFTD. The cohort consisted of C9+ subjects classified as being pre-symptomatic (N = 7), or as having ALS only (N = 9), bvFTD only (N = 3), or both ALS and bvFTD (N = 6). C9+ patients were administered the revised ALS functional rating scale [ALSFRS-R; (40)] to quantify motor impairment related to ALS and the frontal behavioral inventory [FBI; (41)] to assess behavioral impairment related to bvFTD. Twenty-six healthy controls (HC) underwent the same imaging protocol as the C9+ patients as part of a separate IRB-approved study. All healthy controls had normal neurological examinations and a normal cognitive screening test.
Table 1

Demographic information of study groups and sub-groups.

N (males)Age (years)ALSFRS-RFBI
All C9+25 (14)51.74 ± 11.9542.8 ± 6.70.16 ± 0.17
ALS9 (4)51.85 ± 9.9541.6 ± 3.80.08 ± 0.08
ALS-FTD6 (6)60.72 ± 10.1941.8 ± 5.30.31 ± 0.08
bvFTD3 (3)60.59 ± 5.1146.0 ± 2.70.36 ± 0.2
HC26 (16)52.33 ± 8.79--
Demographic information of study groups and sub-groups.

Imaging Protocol

Participants underwent MRI scanning on a GE 3T scanner. Two T1 FSPGR anatomical scans were collected (TI = 450 ms, α = 13°, voxel size = 1 × 0.938 × 0.938 mm). Resting state functional scans were collected during which subjects were instructed to stay awake, keep their eyes open, and think random thoughts (TR = 2,000 ms, TE = 30 ms, flip angle = 77, voxel size = 3.75 × 3.75 × 3.8 mm, FOV = 64 × 64 cm, 40 slices, 214 volumes).

Image Processing

Anatomical MRI data were processed in FreeSurfer and each subject's gray matter was parcellated into 82 volumes of interest (VOIs). These VOIs consisted of 34 cortical regions per hemisphere based on the Desikan-Killiany atlas (42) plus 14 subcortical VOIs, excluding the cerebellum (Table 2). Resting state functional data were preprocessed using FSL and custom MATLAB scripts. Preprocessing steps included motion and slice time correction, volume scrubbing based on motion outliers (identified by FSL's calculation of framewise displacement and the derivative of the time-course of root mean square intensity across voxels [DVARS; (43)], regression of motion parameters and white matter and CSF signals, and bandpass filtering between 0.01 and 0.1 Hz. Each subject's functional image was registered to their structural image. The anatomical parcellation and segmentation were applied to the functional time series to extract the 82 VOIs, and all the voxels within each VOI were averaged at every time point to create a time series of average signal for each VOI.
Table 2

Volumes of interest used in the analysis and their abbreviations and color scheme as displayed in Figure 3.

Region nameAbbreviationRegion nameAbbreviation
Frontal poleFront-poleCaudate
Superior frontal gyrusSFGPutamen
Lateral orbitofrontal cortexLat-OFCAccumbens areaAccumbens
Medial orbitofrontal cortexMed-OFCPallidum
Rostral middle frontal gyrusRost-MFGTemporal poleTemp-pole
Pars triangularisPars-triSuperior temporal gyrusSTG
Pars orbitalisPars-orbTransverse temporal gyrusTransverse
Pars opercularisPars-opercBanks of the superior temporal sulcusBanks-STS
Caudal middle frontal gyrusCaud-MFGMiddle temporal gyrusMTG
Precentral gyrusPrecentralsInferior temporal gyrusITG
Paracentral lobuleParacentralFusiform gyrusFusiform
Rostral anterior cingulate cortexRost-ACCInsula
Caudal anterior cingulate cortexCaud-ACCPost-central gyrusPost-central
Posterior cingulate cortexPCCSupramarginal gyrusSupramarg
Isthmus of the cingulate cortexIsth-CCSuperior parietal cortexSPC
AmygdalaInferior parietal cortexIPC
ThalamusPrecuneus
HippocampusCuneus
Entorhinal cortexEntorhinalLateral occipital cortexLat-OC
Parahippocampal gyrusParahippPericalcarine cortexPericalc
Lingual gyrusLingual

Each region had a right and left representation.

Blue, frontal lobe; green, limbic system; yellow, basal ganglia; orange, temporal lobe; red, parietal lobe; purple, occipital lobe.

Volumes of interest used in the analysis and their abbreviations and color scheme as displayed in Figure 3.
Figure 3

Edges with reduced connectivity strength in C9+ carriers compared with HC. Significance was determined using permutation testing at p < 0.001 uncorrected. See Table 2 for region name abbreviations.

Each region had a right and left representation. Blue, frontal lobe; green, limbic system; yellow, basal ganglia; orange, temporal lobe; red, parietal lobe; purple, occipital lobe.

Graph Theory Analysis and Statistics

A connectivity matrix was formed with each row and column representing a node (VOI) and each cell representing an edge with strength equal to the Pearson correlation coefficient (R) of the row/column pair. Fisher transformation was applied to permit multiple linear regression of age and gender effects, followed by back transformation to R. The matrices were then thresholded by setting all connections below a specific R to zero. Thresholds from 0 to 0.7 were tested in increments of 0.1; thresholds >0.7 resulted in matrices too sparse for the calculation of may graph metrics. Thresholds between 0 and 0.4 yielded similar statistical results in global metrics, so R ≥ 0.2 was selected as the representative threshold for reporting. Graph theory metrics were calculated using custom MATLAB scripts and the Brain Connectivity Toolbox [https://sites.google.com/site/bctnet (37)]. Two group analyses were performed: (1) all C9+ vs. HC and (2) a sub-analysis of C9+ subjects in which symptomatic bvFTD+ patients (bvFTD and ALS-FTD, n = 9) were compared to symptomatic ALS-only patients (ALS only, n = 9). Group differences for both analyses were evaluated using global, nodal, and edge metrics (Table 3). Global metrics included network density, mean connection strength, mean node clustering coefficient, mean node path length, and modularity score. Nodal measures included node strength, closeness centrality, betweenness centrality, within-module degree Z score, and participation coefficient. Hubs, or nodes that are particularly highly connected and involved within the network, were identified with a composite hub score that was calculated by summing the Z scores of the five nodal measures.
Table 3

Description of graph analysis metrics.

Global MetricDescription
 Network densityFraction of all possible connections above the connection threshold
 Mean connection strengthAverage connection strength of connections above the connection threshold
 Clustering CoefficientExtent of node clustering; a measure of how often the neighbors of a node are also neighbors of each other
 Path LengthLowest number of connections required to travel between each node pair in the network
 Modularity scoreAbility of the network to be segregated into discrete modules
Nodal MetricDescription
 Node strengthSum of the strength of connections to all other nodes in the network
 Closeness centralityNearness to all other nodes in the network
 Betweenness centralityFrequency at which the node lies on the shortest path between two other nodes
 Within-module degree Z-scoreConnectedness of a node within its own module
 Participation coefficientConnectedness of a node to nodes in other modules
Description of graph analysis metrics. Permutation testing was used to calculate effective p-values (44). In each permutation, subjects' group assignments were randomly shuffled and the difference in the metric of interest between the two shuffled groups was calculated. The effective p-value was defined as the fraction of total permutations in which the shuffled groups had a larger magnitude of difference in the graph metric than the actual study groups. 1 × 103 permutations were used to ensure a sufficient number of significant figures for reporting.

Results

Comparison of C9+ Carriers With Healthy Controls

Global Graph Metrics—C9+ vs. HC

Analysis of global measures revealed that the C9+ carrier group had significantly lower global network density than HC, with fewer connections with strength greater than the correlation threshold (Figures 1, 2). Those edges that survived thresholding had a significantly lower mean connection strength for C9+ than HC (Figure 2). The clustering coefficients were also significantly different between groups (p = 0.018). However, because path length and modularity score are sensitive to network density (45), any significant differences are likely to be influenced by the different network densities, so they were not further explored.
Figure 1

Resting state functional connectivity matrix thresholded at R ≥ 0.2. Bottom left: HC mean connectivity matrix. Top right: C9+ mean connectivity matrix. Scale bar shows Pearson correlation coefficient.

Figure 2

Global network measures in which C9+ carriers significantly differed from HC.

Resting state functional connectivity matrix thresholded at R ≥ 0.2. Bottom left: HC mean connectivity matrix. Top right: C9+ mean connectivity matrix. Scale bar shows Pearson correlation coefficient. Global network measures in which C9+ carriers significantly differed from HC.

Network Hubs—C9+ Carriers vs. Healthy Controls

There was minimal reorganization of hub nodes in C9+ carriers compared to the healthy control group. The composite hub score showed that 75% of the nodes comprising the top 20% of hub scores were the same for HC and C9+ carriers (Table 4). Moreover, with the exception of one node in the top 20% in each group, hubs were ranked within the top 30% in the other group or were the contralateral pair to one of the top 20% nodes. The single hub that was highly ranked in healthy controls but not C9+ was the left lateral orbitofrontal cortex. The single hub that ranked highly in the C9+ carrier group but not healthy controls was the left thalamus.
Table 4

Group hubs, defined as the top 20% of nodes based on a composite hub score (Z) for Healthy Controls and C9+ carrier groups.

HCC9+
VOIZcompositeVOIZcomposite
L Fusiform gyrus6.740R Middle temporal gyrus8.226
L Middle temporal gyrus5.090R Fusiform gyrus6.753
R Inferior temporal gyrus4.952R Lingual gyrus6.692
R Lateral orbitofrontal cortex4.701R Superior temporal gyrus6.135
R Middle temporal gyrus4.303L Posterior cingulate cortex5.693
R Fusiform gyrus4.180L Putamen5.541
L Putamen4.068R Superior frontal gyrus5.294
L Lateral orbitofrontalcortex4.007L Lingual gyrus4.707
L Inferior parietal cortex3.904L Superior frontal gyrus4.628
R Superior frontal gyrus3.722L Inferior parietal cortex4.409
L Lingual gyrus3.630L Superior temporal gyrus4.211
R Posterior cingulate cortex3.608L Precentral gyrus4.111
R Lingual gyrus3.514L Fusiform gyrus3.235
L Superior temporal gyrus3.489R Lateral orbitofrontal cortex3.112
R Superior temporal gyrus3.345L Inferior temporal gyrus3.110
L Posterior cingulate cortex3.042L Thalamus3.046

L, left, R, right; shared hubs shown in bold; hubs where the same contralateral region is a hub shown in italics; hubs that were not highly ranked in the comparison group are underlined. Z.

Group hubs, defined as the top 20% of nodes based on a composite hub score (Z) for Healthy Controls and C9+ carrier groups. L, left, R, right; shared hubs shown in bold; hubs where the same contralateral region is a hub shown in italics; hubs that were not highly ranked in the comparison group are underlined. Z.

Edge Analysis—C9+ vs. HC

Figure 3 displays the edges that had significantly decreased functional connectivity in C9+ carriers compared to HC (p < 0.001 uncorrected). There were no impaired intra-hemispheric connections in the left hemisphere. All connections with decreased functional connectivity were either inter-hemispheric or intra-hemispheric within the right hemisphere. More cortical connections were affected than subcortical connections. The right frontal lobe had the greatest number of reduced connections. Reduced connectivity was also seen for connections with the basal ganglia, temporal lobe, and parietal lobes. These edges connect regions involved in a broad range of cognitive functions. Additionally, several edges connecting motor-related regions were affected, including the right precentral and paracentral lobules. Other regions having multiple differing connections were the pars opercularis, pars triangularis, supramarginal gyrus, inferior temporal gyrus, and the left putamen. Edges with reduced connectivity strength in C9+ carriers compared with HC. Significance was determined using permutation testing at p < 0.001 uncorrected. See Table 2 for region name abbreviations.

Comparison of C9+ bvFTD/ALS-FTD Carriers With C9+ ALS Alone (bvFTD-)

Global Graph Metrics—bvFTD+ vs. ALS-only

Within the symptomatic group of C9+ carriers, there were no significant differences in global metrics (network density, mean connection strength, clustering coefficient, path length, and modularity) between the nine patients with ALS alone and the nine patients with bvFTD or ALS-FTD.

Network Hubs—bvFTD+ vs. ALS-only

The ALS-only group had similar hubs to healthy controls, with the addition of the precentral gyri and right caudate. In contrast, the bvFTD+ group had several nodes with hub scores that were ranked much lower than in the ALS-only group and healthy controls. These hubs included bilateral thalamus, right hippocampus, and right lateral occipital cortex. Hubs are listed in Table 5.
Table 5

Group hubs, defined as top 20% of nodes based on composite hub score for symptomatic patients with and without bvFTD.

C9+ bvFTD+ (n = 9)C9+ ALS-only (n = 9)
VOIZcompositeVOIZcomposite
L Posterior cingulate cortex9.512R Superior temporal gyrus8.346
L Superior temporal gyrus7.121R Lingual gyrus7.159
R Superior frontal gyrus6.652R Middle temporal gyrus6.744
L Superior frontal gyrus6.437L Middle temporal gyrus6.483
L Putamen6.391L Superior temporal gyrus5.412
R Superior temporal gyrus5.528R Caudate5.135
R Fusiform gyrus5.102R Banks STS4.803
R Thalamus5.022R Inferior parietal cortex4.639
L Thalamus4.732R Superior frontal gyrus4.535
R Lingual gyrus4.629R Precentral gyrus4.425
R Lateral occipital cortex4.124L Lingual gyrus4.330
L Pericalcarine cortex4.069R Caudal anterior cingulate cortex3.925
L Inferior temporal gyrus3.797L Superior frontal gyrus3.862
R Middle temporal gyrus3.732R Isthmus of the cingulate cortex3.810
R Inferior parietal cortex3.728R Inferior temporal gyrus3.734
R Hippocampus3.626L Precentral gyrus3.596

L, left, R, right; shared hubs shown in bold; hubs where the same contralateral region is a hub shown in italics; hubs that were not highly ranked in the comparison group are underlined. Z.

Group hubs, defined as top 20% of nodes based on composite hub score for symptomatic patients with and without bvFTD. L, left, R, right; shared hubs shown in bold; hubs where the same contralateral region is a hub shown in italics; hubs that were not highly ranked in the comparison group are underlined. Z. The correlations between the hub score and the FBI and ALSFRS-R scores were computed for each of the unique hubs within each group. Three of the unique hubs in bvFTD+ patients correlated with FBI scores across all symptomatic C9+, indicating that behavioral impairment was associated with higher node strength (Figure 4). These hub nodes were the left thalamus (R = 0.443, p = 0.066), right thalamus (R = 0.471, p = 0.049), and right hippocampus (R = 0.525, p = 0.025).
Figure 4

Correlation across all symptomatic C9+ carriers of Frontal Behavioral Inventory Scores with node strength of hubs that were more highly ranked in the bvFTD+ group than ALS-only group. (A) Left thalamus, R = 0.443, p = 0.066 (B) Right thalamus, R = 0.471, p = 0.049 (C) Right hippocampus, R = 0.525, p = 0.025.

Correlation across all symptomatic C9+ carriers of Frontal Behavioral Inventory Scores with node strength of hubs that were more highly ranked in the bvFTD+ group than ALS-only group. (A) Left thalamus, R = 0.443, p = 0.066 (B) Right thalamus, R = 0.471, p = 0.049 (C) Right hippocampus, R = 0.525, p = 0.025.

Edge Analysis—C9+ bvFTD+ vs. ALS-only

Several edges had reduced connectivity strength in the ALS-only group compared to the bvFTD+ group. All statistically significant differences consisted of decreases in connection strength in the ALS-only group compared with the bvFTD+ group. The frontal and temporal regions exhibited the greatest number of decreased connections (Figure 5).
Figure 5

Edges with reduced connectivity strength in ALS-only group compared with bvFTD+/ALS-FTD. Significance was determined using permutation testing at p < 0.001 uncorrected. See Table 2 for region name abbreviations.

Edges with reduced connectivity strength in ALS-only group compared with bvFTD+/ALS-FTD. Significance was determined using permutation testing at p < 0.001 uncorrected. See Table 2 for region name abbreviations.

Discussion

In this study, we used graph theory metrics to explore alterations in network organization in C9orf72 mutation carriers and network correlations with motor and cognitive-behavioral functional measures. Graph theory allows exploration of network organization and functionality as a whole, rather than correlations between activity in discrete regions. We found that global network measures of connectivity were reduced in a cohort of C9+ carriers with heterogenous symptoms compared to healthy controls. Because C9orf72 expansion mutations cause motor and cognitive-behavioral symptoms across the ALS-FTD spectrum, we had anticipated that brain regions known to be affected in sporadic forms of both diseases would exhibit connectivity changes. This was mostly confirmed, with reduced connectivity specifically found in connections involving the frontal and temporal regions and the right motor cortex, regions known to be involved in cognitive and motor function. These findings are consistent with many prior studies in sporadic and C9+ FTD (13, 15, 22, 33, 35, 46–51). However, as previously noted, the literature on resting state connectivity in sporadic ALS has many discordant results. Our findings are consistent with studies showing decreased connectivity in ALS (29, 30, 32, 35, 52). The nodes with the greatest numbers of impaired connections in the C9+ population represented regions that are involved in networks previously described as being affected in ALS and bvFTD. These regions–the right precentral, paracentral, supramarginal, and inferior temporal gyri, the pars opercularis, pars triangularis, and the left putamen–are parts of the sensorimotor, salience, and central executive networks (53, 54). Interestingly, while overall connectivity was decreased in the C9+ group, there appeared to be no substantial reorganization of network hubs. This indicates a relatively diffuse global decline in connectivity. Further underscoring this point, the edge analysis found no regions with increased connectivity in the C9+ network compared to HCs. This relative preservation of network organization may be interpreted as supporting the proposal that networks can compensate for low grade degeneration for a substantial period in order to maintain clinical function (55, 56). An alternative possibility is that pooling C9+ ALS, ALS-FTD, bvFTD, and pre-symptomatic carriers into one analysis group masked phenotype-specific network alterations. To explore this possibility, we compared subgroups of C9+ symptomatic patients with and without FTD. This analysis found no significant differences in global network measures between subgroups, indicating that the global decrease in connectivity observed in the full C9+ cohort was likely not solely driven by a large change in one of the phenotypic subgroups. However, nodal graph theory metrics revealed some organizational differences between subgroups. Both of the symptomatic phenotypic subgroups had several hubs that that were unique in comparison with the healthy controls and from the other subgroup. In the ALS-only group (i.e., patients without FTD), the bilateral precentral gyri emerged as group-specific hubs. This implies that the ALS-only subgroup either had small increases in motor cortex connectivity or that the motor cortex connectivity remained relatively stable in the face of declining connectivity of the more active nodes. This phenomenon is consistent with resting state studies of patients with sporadic ALS that demonstrate localized increases in connectivity of motor regions (15, 25, 28, 57), and could represent a compensatory mechanism or the relative resilience of the motor network. The bvFTD+ group had a greater number of subcortical hubs. The bilateral thalami and the right hippocampus were hub nodes in the bvFTD+ group and were not highly ranked in the ALS-only group or in healthy controls. The greater dependence on subcortical nodes could arise as a consequence of structural changes, including cortical atrophy (10, 15, 58, 59). The emergence of the thalamus as an important hub in C9+ bvFTD was somewhat surprising given that thalamic atrophy occurs in bvFTD (13, 16, 60) and in C9+ patients (8, 10, 15, 21). It also seems to conflict with resting state studies of bvFTD that report decreases in thalamic connectivity (47, 61). This may reflect differences between seed-based analysis methods (which may neglect global neuromodulatory changes) vs. the whole-brain approach used here. On balance, these modulated connections could result in the thalamus having a more prominent role as a network hub. The emergence of the hippocampus as a hub may account for the preservation of memory in the first few years of bvFTD symptoms (39, 60), although there are a few reports of hippocampal atrophy in bvFTD (48, 62). To investigate the relationship between disease severity and network hub changes, we evaluated the correlation between hub scores of hubs unique to each subgroup and the FBI and ALSFRS-R scores of symptomatic C9+ carriers. The hub scores of the bilateral thalami and right hippocampus correlated with behavioral impairment as measured by the FBI. There was also significantly higher connectivity between the right hippocampus and the right and left middle frontal gyrus in the analysis of individual connections in the bvFTD+ group. Therefore, as the thalamus and hippocampus became more hub-like, patients exhibited more severe behavioral impairment. In contrast, there was no association between the hub scores and the ALSFRS-R scores for the unique hubs in the ALS-only group. The connectivity of these motor regions appears to change independently from this measure of motor symptom severity. There are limitations in the present study that warrant discussion. First, because no subjects with sporadic disease were considered for this study, it is impossible to determine if any effects described here are unique to familial (and specifically C9-linked) disease. Second, as a result of our relatively small sample size, there is a large amount of heterogeneity in the study population and functional connectivity data. Subjects were grouped according to meeting diagnostic criteria for ALS and/or bvFTD; however, minor symptoms that were insufficient to meet criteria for a clinical diagnosis could nevertheless affect neural activity. Future studies with larger subgroups are warranted. Third, due to the wide variation in disease severity and duration amongst subjects, our cross-sectional design may not capture the full extent of functional connectivity changes in C9+ disease; a longitudinal study would be better suited to explore the evolution of functional connectivity changes across the ALS-FTD spectrum over time.

Conclusion

Carriers of the C9orf72 repeat expansion mutation have decreased functional connectivity at rest compared with healthy controls. Global network organization is generally preserved, although local network alterations emerge in C9+ carriers with ALS vs. FTD. Subcortical regions, including the bilateral thalami and the right hippocampus, emerge as hubs associated with the severity of behavioral impairment.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by National Institutes of Health Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.

Author Contributions

RS contributed to data collection, analytical design, data analysis and interpretation, and manuscript drafting. MC contributed to data collection, data interpretation, and manuscript editing. MF contributed to project conception and design, data collection, data interpretation, and manuscript editing. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  61 in total

1.  Altered motor network functional connectivity in amyotrophic lateral sclerosis: a resting-state functional magnetic resonance imaging study.

Authors:  Fuqing Zhou; Honghan Gong; Fangjun Li; Ying Zhuang; Yufeng Zang; Renshi Xu; Ze Wang
Journal:  Neuroreport       Date:  2013-08-21       Impact factor: 1.837

2.  Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.

Authors:  Taha Omer; Eoin Finegan; Siobhan Hutchinson; Mark Doherty; Alice Vajda; Russell L McLaughlin; Niall Pender; Orla Hardiman; Peter Bede
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-05-31       Impact factor: 4.092

3.  Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.

Authors:  Esther Verstraete; Martijn P van den Heuvel; Jan H Veldink; Niels Blanken; René C Mandl; Hilleke E Hulshoff Pol; Leonard H van den Berg
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

4.  Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion.

Authors:  Janne M Papma; Lize C Jiskoot; Jessica L Panman; Elise G Dopper; Tom den Heijer; Laura Donker Kaat; Yolande A L Pijnenburg; Lieke H Meeter; Rick van Minkelen; Serge A R B Rombouts; John C van Swieten
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

5.  Functional dissociation between anterior temporal lobe and inferior frontal gyrus in the processing of dynamic body expressions: Insights from behavioral variant frontotemporal dementia.

Authors:  Jan Jastorff; Francois-Laurent De Winter; Jan Van den Stock; Rik Vandenberghe; Martin A Giese; Mathieu Vandenbulcke
Journal:  Hum Brain Mapp       Date:  2016-08-11       Impact factor: 5.038

6.  Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.

Authors:  Susan Byrne; Marwa Elamin; Peter Bede; Aleksey Shatunov; Cathal Walsh; Bernie Corr; Mark Heverin; Norah Jordan; Kevin Kenna; Catherine Lynch; Russell L McLaughlin; Parameswaran Mahadeva Iyer; Caoimhe O'Brien; Julie Phukan; Brona Wynne; Arun L Bokde; Daniel G Bradley; Niall Pender; Ammar Al-Chalabi; Orla Hardiman
Journal:  Lancet Neurol       Date:  2012-02-03       Impact factor: 44.182

7.  Longitudinal diffusion tensor imaging in frontotemporal dementia.

Authors:  Colin J Mahoney; Ivor J A Simpson; Jennifer M Nicholas; Phillip D Fletcher; Laura E Downey; Hannah L Golden; Camilla N Clark; Nicole Schmitz; Jonathan D Rohrer; Jonathan M Schott; Hui Zhang; Sebastian Ourselin; Jason D Warren; Nick C Fox
Journal:  Ann Neurol       Date:  2014-11-17       Impact factor: 10.422

8.  Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.

Authors:  David M Cash; Martina Bocchetta; David L Thomas; Katrina M Dick; John C van Swieten; Barbara Borroni; Daniela Galimberti; Mario Masellis; Maria Carmela Tartaglia; James B Rowe; Caroline Graff; Fabrizio Tagliavini; Giovanni B Frisoni; Robert Laforce; Elizabeth Finger; Alexandre de Mendonça; Sandro Sorbi; Martin N Rossor; Sebastien Ourselin; Jonathan D Rohrer
Journal:  Neurobiol Aging       Date:  2017-10-19       Impact factor: 4.673

9.  Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers.

Authors:  Suzee E Lee; Ana C Sias; Maria Luisa Mandelli; Jesse A Brown; Alainna B Brown; Anna M Khazenzon; Anna A Vidovszky; Theodore P Zanto; Anna M Karydas; Mochtar Pribadi; Deepika Dokuru; Giovanni Coppola; Dan H Geschwind; Rosa Rademakers; Maria Luisa Gorno-Tempini; Howard J Rosen; Bruce L Miller; William W Seeley
Journal:  Neuroimage Clin       Date:  2016-12-10       Impact factor: 4.881

10.  Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.

Authors:  Timothy Rittman; Robin Borchert; Simon Jones; John van Swieten; Barbara Borroni; Daniela Galimberti; Mario Masellis; Maria Carmela Tartaglia; Caroline Graff; Fabrizio Tagliavini; Giovanni B Frisoni; Robert Laforce; Elizabeth Finger; Alexandre Mendonça; Sandro Sorbi; Jonathan D Rohrer; James B Rowe
Journal:  Neurobiol Aging       Date:  2019-01-04       Impact factor: 4.673

View more
  2 in total

Review 1.  Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials.

Authors:  Giorgia Querin; Maria Grazia Biferi; Pierre-Francois Pradat
Journal:  J Neuromuscul Dis       Date:  2022

Review 2.  Brain Connectivity and Network Analysis in Amyotrophic Lateral Sclerosis.

Authors:  Vijay Renga
Journal:  Neurol Res Int       Date:  2022-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.